DotLab's alternatives and competitors
NextGen Jane offers women insights into their reproductive health through a genomics-driven approach to tracking biological changes predictive of disease. Its smart tam…
- TTAnalyst Briefing Submitted
Temple Therapeutics is a pharmaceutical clinical development company with a global footprint, focused on diseases where abnormal tissue growth and dysfunction are commo…
DotLab vs. Temple Therapeutics
- Customer references
Top 2 DotLab competitors
Work for DotLab?
Compete with DotLab?
Brief our analysts.
Get in front of tech buyers.
You May Also Like
AbbVie (NYSE: ABBV) consists of scientists, researchers, communicators, manufacturing specialists, and regulatory professionals who seek to come up with new approaches to addressing today's health issues-from life-threatening illness to chronic conditions. The company focuses its R&D efforts and technology investments to pursue this goal.
NextGen Jane offers women insights into their reproductive health through a genomics-driven approach to tracking biological changes predictive of disease. Its smart tampon allows women to proactively keep track of their health by studying blood samples in the privacy of their homes. The company was founded in 2014 and is based in Oakland, California.
Temple Therapeutics is a pharmaceutical clinical development company with a global footprint, focused on diseases where abnormal tissue growth and dysfunction are common hallmarks and lead to fibrosis, pain, infertility, and cancers. The company was founded in 2020 and is based in Geleen, Netherlands.
Baxter International (NYSE: BAX) is an American healthcare company that provides a broad portfolio of essential renal and hospital products, including home, acute, and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software, and services. The company primarily focuses on products to treat hemophilia, kidney disease, immune disorders, and other chronic and acute medical conditions.
Cheetah Medical is a provider in non-invasive Cardiac Output and Hemodynamic monitoring. The company is focused on development and commercialization of an accurate non-invasive solution for the monitoring of critically ill patients. Cheetah Medical's NICOM Noninvasive Hemodynamic Monitoring System is based on the company's BIOREACTANCE technology.On September 10, 2019, Cheetah Medical was acquired by Baxter at a valuation of between $190M and $230M.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.